Marc Hyer, Ph.D. is a seasoned expert in oncology drug discovery and pharmacology, currently serving as the Director of In Vivo Pharmacology Oncology Research at AstraZeneca. With a robust background in translational medicine and project leadership, they have successfully led teams in various roles, including Senior Scientist at Takeda Oncology and Associate Director at Agios Pharmaceuticals. Marc has been instrumental in advancing multiple small molecule inhibitors through early clinical trials and has authored significant regulatory documents. They hold a Ph.D. in Cellular and Molecular Biology and a Bachelor of Science in Biology from the University of Georgia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices